On December 22, Guilin Sanjin Pharmaceutical Co.Ltd(002275) announced that Zou Jieming, the actual controller and chairman (and legal representative), died of illness on December 21, 2021 at the age of 80.
Zou Jieming directly holds 9.05% equity of Guilin Sanjin Pharmaceutical Co.Ltd(002275) and directly or indirectly holds 41.80% equity of Guilin Sanjin Pharmaceutical Co.Ltd(002275) through himself and his relatives. He is the actual controller of Guilin Sanjin Pharmaceutical Co.Ltd(002275) . As the main founder of Guilin Sanjin Pharmaceutical Co.Ltd(002275) , Zou Jieming has made indelible contributions to the establishment, growth and development of Guilin Sanjin Pharmaceutical Co.Ltd(002275) .
According to the announcement, Zou Jieming, during his tenure as the chairman of Guilin Sanjin Pharmaceutical Co.Ltd(002275) , scrupulously performed his duties and duties, faithfully and honestly performed relevant duties and obligations, and played a positive role in Guilin Sanjin Pharmaceutical Co.Ltd(002275) standardized operation and high-quality development. The board of directors paid high tribute to Zou Jieming’s contributions and efforts during his tenure. Directors, supervisors The senior management and all staff expressed deep condolences on Zou Jieming’s death and expressed deep condolences to his family.
After Zou Jieming’s death, Guilin Sanjin Pharmaceutical Co.Ltd(002275) the number of current directors was reduced from 9 to 8, which was not lower than the minimum number of directors specified in the company law. Guilin Sanjin Pharmaceutical Co.Ltd(002275) relevant candidate arrangements will be made as soon as possible in accordance with relevant laws and regulations and the articles of association.
(Beijing News)
